Sericin microparticles enveloped with metal-organic networks as a pulmonary targeting delivery system for intra-tracheally treating metastatic lung cancer
Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a ser...
Saved in:
| Published in | Bioactive materials Vol. 6; no. 1; pp. 273 - 284 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
01.01.2021
KeAi Publishing KeAi Communications Co., Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a sericin microparticles enveloped with metal-organic networks as a pulmonary delivery system for treating lung metastasis of breast cancer in an animal model. The sericin microparticles (SMPs) were prepared using water in oil (w/o) emulsification method. After doxorubicin (DOX) loading, tannic acid (TA)/ferric irons (Fe3+) based metal organic networks (MON) were coated on the particles to obtain DOX-loaded microparticles (DOX@SMPs-MON). The SMPs-MON with good biocompatibility could effectively encapsulate DOX and sustainably unload cargos in a pH-dependent manner. The DOX-loaded microparticles could be uptaken by 4T1 cells, and effectively kill the cancer cells. In vivo, DOX@SMPs-MON was deposited in the lungs and remained for over 5 days after pulmonary administration. In contrast to conventional DOX treatment that did not show significantly inhibitory effects on lung metastatic tumor, DOX@SMPs-MON markedly decreased the number and size of metastatic nodules in lungs, and the lung weight and appearance were similar to those of healthy mice. In summary, the sericin microparticles with MON wrapping might be a promising pulmonary delivery system for treating lung metastatic cancer.
[Display omitted]
•Biocompatible and biodegradable materials (sericin, tannic acid, ferric iron) based microparticles (SMPs-MON) were developed.•SMPs-MON enhances the doxorubicin accumulation and retention in the lungs as a pulmonary drug release system.•DOX-loaded SMPs-MON could significantly decrease the number and size of metastasis nodules in lungs. |
|---|---|
| AbstractList | Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a sericin microparticles enveloped with metal-organic networks as a pulmonary delivery system for treating lung metastasis of breast cancer in an animal model. The sericin microparticles (SMPs) were prepared using water in oil (w/o) emulsification method. After doxorubicin (DOX) loading, tannic acid (TA)/ferric irons (Fe
3+
) based metal organic networks (MON) were coated on the particles to obtain DOX-loaded microparticles (DOX@SMPs-MON). The SMPs-MON with good biocompatibility could effectively encapsulate DOX and sustainably unload cargos in a pH-dependent manner. The DOX-loaded microparticles could be uptaken by 4T1 cells, and effectively kill the cancer cells. In vivo, DOX@SMPs-MON was deposited in the lungs and remained for over 5 days after pulmonary administration. In contrast to conventional DOX treatment that did not show significantly inhibitory effects on lung metastatic tumor, DOX@SMPs-MON markedly decreased the number and size of metastatic nodules in lungs, and the lung weight and appearance were similar to those of healthy mice. In summary, the sericin microparticles with MON wrapping might be a promising pulmonary delivery system for treating lung metastatic cancer.
Image 1
•
Biocompatible and biodegradable materials (sericin, tannic acid, ferric iron) based microparticles (SMPs-MON) were developed.
•
SMPs-MON enhances the doxorubicin accumulation and retention in the lungs as a pulmonary drug release system.
•
DOX-loaded SMPs-MON could significantly decrease the number and size of metastasis nodules in lungs. Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a sericin microparticles enveloped with metal-organic networks as a pulmonary delivery system for treating lung metastasis of breast cancer in an animal model. The sericin microparticles (SMPs) were prepared using water in oil (w/o) emulsification method. After doxorubicin (DOX) loading, tannic acid (TA)/ferric irons (Fe3+) based metal organic networks (MON) were coated on the particles to obtain DOX-loaded microparticles (DOX@SMPs-MON). The SMPs-MON with good biocompatibility could effectively encapsulate DOX and sustainably unload cargos in a pH-dependent manner. The DOX-loaded microparticles could be uptaken by 4T1 cells, and effectively kill the cancer cells. In vivo, DOX@SMPs-MON was deposited in the lungs and remained for over 5 days after pulmonary administration. In contrast to conventional DOX treatment that did not show significantly inhibitory effects on lung metastatic tumor, DOX@SMPs-MON markedly decreased the number and size of metastatic nodules in lungs, and the lung weight and appearance were similar to those of healthy mice. In summary, the sericin microparticles with MON wrapping might be a promising pulmonary delivery system for treating lung metastatic cancer. Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a sericin microparticles enveloped with metal-organic networks as a pulmonary delivery system for treating lung metastasis of breast cancer in an animal model. The sericin microparticles (SMPs) were prepared using water in oil (w/o) emulsification method. After doxorubicin (DOX) loading, tannic acid (TA)/ferric irons (Fe3+) based metal organic networks (MON) were coated on the particles to obtain DOX-loaded microparticles (DOX@SMPs-MON). The SMPs-MON with good biocompatibility could effectively encapsulate DOX and sustainably unload cargos in a pH-dependent manner. The DOX-loaded microparticles could be uptaken by 4T1 cells, and effectively kill the cancer cells. In vivo, DOX@SMPs-MON was deposited in the lungs and remained for over 5 days after pulmonary administration. In contrast to conventional DOX treatment that did not show significantly inhibitory effects on lung metastatic tumor, DOX@SMPs-MON markedly decreased the number and size of metastatic nodules in lungs, and the lung weight and appearance were similar to those of healthy mice. In summary, the sericin microparticles with MON wrapping might be a promising pulmonary delivery system for treating lung metastatic cancer. [Display omitted] •Biocompatible and biodegradable materials (sericin, tannic acid, ferric iron) based microparticles (SMPs-MON) were developed.•SMPs-MON enhances the doxorubicin accumulation and retention in the lungs as a pulmonary drug release system.•DOX-loaded SMPs-MON could significantly decrease the number and size of metastasis nodules in lungs. Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a sericin microparticles enveloped with metal-organic networks as a pulmonary delivery system for treating lung metastasis of breast cancer in an animal model. The sericin microparticles (SMPs) were prepared using water in oil (w/o) emulsification method. After doxorubicin (DOX) loading, tannic acid (TA)/ferric irons (Fe3+) based metal organic networks (MON) were coated on the particles to obtain DOX-loaded microparticles (DOX@SMPs-MON). The SMPs-MON with good biocompatibility could effectively encapsulate DOX and sustainably unload cargos in a pH-dependent manner. The DOX-loaded microparticles could be uptaken by 4T1 cells, and effectively kill the cancer cells. In vivo, DOX@SMPs-MON was deposited in the lungs and remained for over 5 days after pulmonary administration. In contrast to conventional DOX treatment that did not show significantly inhibitory effects on lung metastatic tumor, DOX@SMPs-MON markedly decreased the number and size of metastatic nodules in lungs, and the lung weight and appearance were similar to those of healthy mice. In summary, the sericin microparticles with MON wrapping might be a promising pulmonary delivery system for treating lung metastatic cancer.Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic efficiency and severe toxic side effects, due to the extremely low delivery efficacy and non-specificity of anticancer drugs. Herein, we report a sericin microparticles enveloped with metal-organic networks as a pulmonary delivery system for treating lung metastasis of breast cancer in an animal model. The sericin microparticles (SMPs) were prepared using water in oil (w/o) emulsification method. After doxorubicin (DOX) loading, tannic acid (TA)/ferric irons (Fe3+) based metal organic networks (MON) were coated on the particles to obtain DOX-loaded microparticles (DOX@SMPs-MON). The SMPs-MON with good biocompatibility could effectively encapsulate DOX and sustainably unload cargos in a pH-dependent manner. The DOX-loaded microparticles could be uptaken by 4T1 cells, and effectively kill the cancer cells. In vivo, DOX@SMPs-MON was deposited in the lungs and remained for over 5 days after pulmonary administration. In contrast to conventional DOX treatment that did not show significantly inhibitory effects on lung metastatic tumor, DOX@SMPs-MON markedly decreased the number and size of metastatic nodules in lungs, and the lung weight and appearance were similar to those of healthy mice. In summary, the sericin microparticles with MON wrapping might be a promising pulmonary delivery system for treating lung metastatic cancer. |
| Author | Yuan, Ye Wang, Zheng Deng, Yan Li, Qilin Wang, Lin Shi, Lin Wang, Guobin Liu, Jia Fu, Daan |
| Author_xml | – sequence: 1 givenname: Jia surname: Liu fullname: Liu, Jia organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 2 givenname: Yan surname: Deng fullname: Deng, Yan organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 3 givenname: Daan surname: Fu fullname: Fu, Daan organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 4 givenname: Ye surname: Yuan fullname: Yuan, Ye organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 5 givenname: Qilin surname: Li fullname: Li, Qilin organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 6 givenname: Lin surname: Shi fullname: Shi, Lin organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 7 givenname: Guobin surname: Wang fullname: Wang, Guobin email: wgb@hust.edu.cn organization: Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 8 givenname: Zheng surname: Wang fullname: Wang, Zheng email: zhengwang@hust.edu.cn organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China – sequence: 9 givenname: Lin surname: Wang fullname: Wang, Lin email: lin_wang@hust.edu.cn organization: Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China |
| BookMark | eNqFks1u1DAQgCNUREvpM-Ajlyy2443jA0hVVaBSJQ6AxM2aOJNdL4692N6t-io8LU53QZRLJf-MxzOf5u9ldeKDx6p6zeiCUda-3Sx6G8DkCfKCU04XtFtQ2j6rzrhY8pop9f3kH_m0ukhpQyllshxUvqhOG65YoxpxVv36gtEa68lkTQxbiNkah4mg36MLWxzInc1rMmEGV4e4Am8N8ZjvQvyRCJRFtjs3BQ_xnmSIK8zWr8iAzu6xqNJ9yjiRMURifY5Ql23WCM4V84jwYD3TUy6yIW5X3ga8wfiqej6CS3hxvM-rbx-uv159qm8_f7y5urytzZJ1uUZkCHyJA5M4dK0EoMDVwEEqWkogxnFklIJsm970SnXU9FIN2NMGKe2VaM6rmwN3CLDR22inkosOYPWDoiStj2XRreGjWna8gIygPcBAhWSjFF0vBe95Yb0_sLa7fsLB4JyzewR9_OPtWq_CXktRkumaAnhzBMTwc4cp68kmg86Bx7BLmgvBWiaWYo773cG0NC6liKM2di5imMnWaUb1PC56o_-Oi57HRdNOl3Ep_vI__z9hPu15efDE0pa9xaiTsVh6NtiIJpe62ScZvwFf9eau |
| CitedBy_id | crossref_primary_10_1016_j_bioactmat_2021_02_028 crossref_primary_10_1021_acsami_3c05645 crossref_primary_10_1021_acs_biomac_1c01279 crossref_primary_10_1021_acs_molpharmaceut_3c00767 crossref_primary_10_1002_smll_202305490 crossref_primary_10_1002_mabi_202300167 crossref_primary_10_1021_acsapm_1c01515 crossref_primary_10_1007_s12247_021_09582_1 crossref_primary_10_1007_s40883_024_00346_0 crossref_primary_10_1016_j_jconrel_2022_02_021 crossref_primary_10_1002_adhm_202100793 crossref_primary_10_1039_D1RA07657D crossref_primary_10_1038_s41598_023_33844_2 crossref_primary_10_1021_acs_nanolett_1c04573 crossref_primary_10_1016_j_cej_2022_136835 crossref_primary_10_1021_acsbiomaterials_1c01426 crossref_primary_10_1002_adma_202210517 crossref_primary_10_1016_j_ijbiomac_2024_129391 crossref_primary_10_1021_acssuschemeng_3c04264 crossref_primary_10_1002_smll_202207199 crossref_primary_10_1016_j_bioactmat_2022_05_017 crossref_primary_10_1016_j_biomaterials_2022_121638 crossref_primary_10_1016_j_jconrel_2022_11_019 |
| Cites_doi | 10.1016/j.ijpharm.2020.119338 10.1016/j.addr.2016.03.012 10.1016/S0959-8049(11)70145-9 10.1517/17425247.2015.1039509 10.1016/j.cocis.2014.07.002 10.1002/adhm.201500355 10.1016/j.msec.2015.12.082 10.1007/s10534-016-9952-2 10.1016/j.addr.2014.12.003 10.1016/j.ijpharm.2007.01.016 10.7150/thno.39816 10.7150/thno.21466 10.1016/j.colsurfb.2014.07.020 10.1038/srep07064 10.1126/science.1237265 10.1021/la703900k 10.1002/0471142735.im2002s39 10.1002/anie.201311136 10.1016/j.biomaterials.2018.02.016 10.1016/j.biotechadv.2015.10.014 10.1016/j.biomaterials.2013.05.018 10.1021/acsbiomaterials.8b00150 10.2147/IJN.S29997 10.1016/j.actbio.2018.09.013 10.1016/j.biomaterials.2008.03.033 10.1021/acsami.6b00959 10.1016/j.addr.2018.08.012 10.1007/s10555-016-9618-0 10.1016/j.ejpb.2014.09.012 10.1021/acsami.8b05232 10.1016/j.addr.2014.05.017 10.3322/caac.21492 10.1016/j.colsurfb.2010.07.050 10.1177/0734242X11404733 10.1016/j.pharmthera.2017.06.002 10.1016/j.jconrel.2011.10.030 10.3390/molecules23123319 10.1016/j.addr.2014.05.008 10.1016/j.biomaterials.2013.06.041 10.1038/onc.2009.196 10.1016/j.jconrel.2017.11.036 10.1016/j.biomaterials.2012.04.018 10.1016/j.ctrv.2013.10.001 10.1007/s13402-018-0376-6 10.1038/aps.2017.34 10.1016/S0014-2999(02)02733-4 10.1016/j.biomaterials.2015.03.005 10.7150/thno.39502 10.1021/acsami.5b11617 10.1016/j.addr.2009.03.009 10.1023/A:1018910200420 10.1016/j.nantod.2016.12.012 10.1016/j.actbio.2009.03.026 10.7150/thno.44569 |
| ContentType | Journal Article |
| Copyright | 2020 2020 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2020 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2020 |
| Copyright_xml | – notice: 2020 – notice: 2020 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. – notice: 2020 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2020 |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.bioactmat.2020.08.006 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2452-199X |
| EndPage | 284 |
| ExternalDocumentID | oai_doaj_org_article_6c2f9582cb9c40baad0471f748b742b2 PMC7451883 10_1016_j_bioactmat_2020_08_006 S2452199X20301523 |
| GroupedDBID | 0SF 6I. AACTN AAEDW AAFTH AALRI AAXUO ABMAC ACGFS ADBBV AEXQZ AFTJW AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BCNDV EBS EJD FDB GROUPED_DOAJ HYE M41 NCXOZ OK1 ROL RPM SSZ 0R~ AAYWO AAYXX ABJCF ACVFH ADCNI ADMLS ADVLN AEUPX AFKRA AFPUW AIGII AKBMS AKRWK AKYEP BBNVY BENPR BGLVJ BHPHI CCPQU CITATION HCIFZ KB. M7P M~E PDBOC PHGZM PHGZT PIMPY 7X8 5PM |
| ID | FETCH-LOGICAL-c518t-ee1ea25ed17ed867aa0a29d2a7904524fff100a763bcb9980cb79deb03e00b943 |
| IEDL.DBID | DOA |
| ISSN | 2452-199X |
| IngestDate | Wed Aug 27 01:21:00 EDT 2025 Thu Aug 21 18:34:52 EDT 2025 Fri Jul 11 09:12:04 EDT 2025 Tue Jul 01 02:11:23 EDT 2025 Thu Apr 24 22:54:43 EDT 2025 Wed May 17 01:53:44 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Pulmonary delivery system Sericin microparticles Doxorubicin Metal organic networks Metastatic lung cancer |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c518t-ee1ea25ed17ed867aa0a29d2a7904524fff100a763bcb9980cb79deb03e00b943 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
| OpenAccessLink | https://doaj.org/article/6c2f9582cb9c40baad0471f748b742b2 |
| PMID | 32913934 |
| PQID | 2441614544 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6c2f9582cb9c40baad0471f748b742b2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7451883 proquest_miscellaneous_2441614544 crossref_citationtrail_10_1016_j_bioactmat_2020_08_006 crossref_primary_10_1016_j_bioactmat_2020_08_006 elsevier_sciencedirect_doi_10_1016_j_bioactmat_2020_08_006 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Bioactive materials |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V KeAi Publishing KeAi Communications Co., Ltd |
| Publisher_xml | – name: Elsevier B.V – name: KeAi Publishing – name: KeAi Communications Co., Ltd |
| References | Aramwit, Siritientong, Srichana (bib42) 2012; 30 Lee, Loo, Ghadiri, Leong, Young, Traini (bib18) 2018; 133 Tseng, Wu, Wang, Peng, Lin, Lin, Young, Shieh (bib15) 2008; 29 Wang, Zhang, Zhang, Huang, Liu, Li, Zhang, Kundu, Wang (bib29) 2014; 4 Yousefi, Nosrati, Salmaninejad, Dehghani, Shahryari, Saberi (bib3) 2018; 41 Kim, Byeon, Kim, Lee, Oh, Shin, Lee, Youn (bib11) 2013; 34 Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib1) 2018; 68 Ramot, Haim-Zada, Domb, Nyska (bib25) 2016; 107 Burris (bib6) 2009; 28 Liu, Qi, Tao, Zhang, Zhang, Xu, Jiang, Zhang, Huang, Li, Xie, Gao, Shuai, Wang, Wang, Wang (bib34) 2016; 8 Huang, Tao, Liu, Qi, Xu, Chang, Gao, Shuai, Wang, Wang, Wang (bib33) 2016; 8 Lee, Loo, Traini, Young (bib7) 2015; 12 Guo, Ping, Ejima, Alt, Meissner, Richardson, Yan, Peter, von Elverfeldt, Hagemeyer, Caruso (bib52) 2014; 53 Liu, Liu, Yuan, Li, Chang, Xu, Cai, Qi, Li, Jiang, Wang, Wang, Wang (bib43) 2018; 10 Luo, Qiao, Zhang, Yang, Cao, Yuan, Ran, Wang, Hao, Cao, Ren, Zhou (bib53) 2020; 10 Luo, Cheng, Zhao, Fu, Xie, Zhang, Pan, Zhang (bib45) 2018; 23 Alipour, Montaseri, Tafaghodi (bib23) 2010; 81 Wood, Pernemalm, Crosbie, Whetton (bib2) 2014; 40 Cao, Zhang (bib38) 2016; 61 Loira-Pastoriza, Todoroff, Vanbever (bib12) 2014; 75 Waqar, Morgensztern (bib4) 2017; 180 Chiou, Shum, Peng, Chen, Chou (bib46) 2003; 458 d'Angelo, Conte, La Rotonda, Miro, Quaglia, Ungaro (bib14) 2014; 75 Ejima, Richardson, Caruso (bib39) 2017; 12 Popper (bib48) 2016; 35 Vanbever, Mintzes, Wang (bib50) 1999; 16 Kim, Byeon, Kim, Lee, Oh, Shin, Lee, Youn (bib10) 2012; 33 Johnston (bib5) 2011; 47 Kwon, Bae, Kim, Na, Lee (bib51) 2007; 333 Aggarwal, Hall, McLeland, Dobrovolskaia, McNeil (bib44) 2009; 61 Ejima, Richardson, Liang, Best, van Koeverden, Such, Cui, Caruso (bib41) 2013; 341 Xie, Yang, Chen, Zhang, Lu, Zhao, Huang, Li, Chang, Wang, Wang (bib31) 2015; 4 Zhu, Yang, Tang, Li, Chu, Liu, Wang, Wu, Zhang (bib26) 2015; 53 Gao, Li, Zhou (bib13) 2017; 38 Chen, Zhan, Wang, Han, Tao, Luo, Ma, Wang, Li, Fan, Li, Den, Cao (bib36) 2018; 80 Kang, Wu, Yin, Huang, Liao, Yao, Ouyang, Wang, Yang (bib22) 2008; 24 Cheng, Davoudi, Xing, Yu, Cheng, Li, Deng, Wang (bib37) 2018; 4 Qi, Liu, Jin, Xu, Wang, Wang, Wang (bib32) 2018; 163 Pulaski, Ostrand-Rosenberg (bib47) 2000; 39 Beck-Broichsitter, Schweiger, Schmehl, Gessler, Seeger, Kissel (bib20) 2012; 158 Shi, Li, Gao, Zhang, Han, Zhang, Shi, Li (bib21) 2014; 122 Conde, Tian, Hernandez, Bao, Cui, Janssen, Ibarra, Baptista, Stoeger, de la Fuente (bib54) 2013; 34 Feng, Tian, Xu, Lin, Xie, Lam, Liang, Chen (bib19) 2014; 88 Joye, McClements (bib17) 2014; 19 Zarogoulidis, Chatzaki, Porpodis, Domvri, Hohenforst-Schmidt, Goldberg, Karamanos, Zarogoulidis (bib16) 2012; 7 Wu, Wen, Wang, Wang, Sun, Wang, Zhang, Williams, Stacy, Chen, Schmieder, Lanza, Shen (bib9) 2018; 8 Abdelaziz, Gaber, Abd-Elwakil, Mabrouk, Elgohary, Kamel, Kabary, Freag, Samaha, Mortada, Elkhodairy, Fang, Elzoghby (bib27) 2018; 269 Lamboni, Gauthier, Yang, Wang (bib28) 2015; 33 Qi, Deng, Xu, Yang, Zhu, Wang, Wang, Wang (bib35) 2020; 10 Fukushige, Tagami, Naito, Goto, Hirai, Hatayama, Yokota, Yasui, Baba, Ozeki (bib24) 2020; 583 Mandal, Priya, Kundu (bib30) 2009; 5 Garbuzenko, Kuzmov, Taratula, Pine, Minko (bib8) 2019; 9 Wang, Cheng, Peng, Zhou, Li, Langer (bib49) 2015; 91 Duck, Connor (bib40) 2016; 29 Luo (10.1016/j.bioactmat.2020.08.006_bib45) 2018; 23 Aggarwal (10.1016/j.bioactmat.2020.08.006_bib44) 2009; 61 Burris (10.1016/j.bioactmat.2020.08.006_bib6) 2009; 28 Cao (10.1016/j.bioactmat.2020.08.006_bib38) 2016; 61 Kim (10.1016/j.bioactmat.2020.08.006_bib11) 2013; 34 Johnston (10.1016/j.bioactmat.2020.08.006_bib5) 2011; 47 Bray (10.1016/j.bioactmat.2020.08.006_bib1) 2018; 68 Wu (10.1016/j.bioactmat.2020.08.006_bib9) 2018; 8 Pulaski (10.1016/j.bioactmat.2020.08.006_bib47) 2000; 39 Huang (10.1016/j.bioactmat.2020.08.006_bib33) 2016; 8 Guo (10.1016/j.bioactmat.2020.08.006_bib52) 2014; 53 Kim (10.1016/j.bioactmat.2020.08.006_bib10) 2012; 33 Fukushige (10.1016/j.bioactmat.2020.08.006_bib24) 2020; 583 Zhu (10.1016/j.bioactmat.2020.08.006_bib26) 2015; 53 Waqar (10.1016/j.bioactmat.2020.08.006_bib4) 2017; 180 Gao (10.1016/j.bioactmat.2020.08.006_bib13) 2017; 38 Luo (10.1016/j.bioactmat.2020.08.006_bib53) 2020; 10 Duck (10.1016/j.bioactmat.2020.08.006_bib40) 2016; 29 Aramwit (10.1016/j.bioactmat.2020.08.006_bib42) 2012; 30 Chen (10.1016/j.bioactmat.2020.08.006_bib36) 2018; 80 Cheng (10.1016/j.bioactmat.2020.08.006_bib37) 2018; 4 Vanbever (10.1016/j.bioactmat.2020.08.006_bib50) 1999; 16 Popper (10.1016/j.bioactmat.2020.08.006_bib48) 2016; 35 Mandal (10.1016/j.bioactmat.2020.08.006_bib30) 2009; 5 Lee (10.1016/j.bioactmat.2020.08.006_bib18) 2018; 133 Liu (10.1016/j.bioactmat.2020.08.006_bib34) 2016; 8 Beck-Broichsitter (10.1016/j.bioactmat.2020.08.006_bib20) 2012; 158 Joye (10.1016/j.bioactmat.2020.08.006_bib17) 2014; 19 Yousefi (10.1016/j.bioactmat.2020.08.006_bib3) 2018; 41 Abdelaziz (10.1016/j.bioactmat.2020.08.006_bib27) 2018; 269 Qi (10.1016/j.bioactmat.2020.08.006_bib35) 2020; 10 Tseng (10.1016/j.bioactmat.2020.08.006_bib15) 2008; 29 Garbuzenko (10.1016/j.bioactmat.2020.08.006_bib8) 2019; 9 Wang (10.1016/j.bioactmat.2020.08.006_bib29) 2014; 4 Qi (10.1016/j.bioactmat.2020.08.006_bib32) 2018; 163 Ramot (10.1016/j.bioactmat.2020.08.006_bib25) 2016; 107 Conde (10.1016/j.bioactmat.2020.08.006_bib54) 2013; 34 Shi (10.1016/j.bioactmat.2020.08.006_bib21) 2014; 122 Ejima (10.1016/j.bioactmat.2020.08.006_bib41) 2013; 341 Zarogoulidis (10.1016/j.bioactmat.2020.08.006_bib16) 2012; 7 Lee (10.1016/j.bioactmat.2020.08.006_bib7) 2015; 12 Kang (10.1016/j.bioactmat.2020.08.006_bib22) 2008; 24 Wood (10.1016/j.bioactmat.2020.08.006_bib2) 2014; 40 Ejima (10.1016/j.bioactmat.2020.08.006_bib39) 2017; 12 Liu (10.1016/j.bioactmat.2020.08.006_bib43) 2018; 10 Kwon (10.1016/j.bioactmat.2020.08.006_bib51) 2007; 333 Loira-Pastoriza (10.1016/j.bioactmat.2020.08.006_bib12) 2014; 75 Chiou (10.1016/j.bioactmat.2020.08.006_bib46) 2003; 458 Lamboni (10.1016/j.bioactmat.2020.08.006_bib28) 2015; 33 Feng (10.1016/j.bioactmat.2020.08.006_bib19) 2014; 88 d'Angelo (10.1016/j.bioactmat.2020.08.006_bib14) 2014; 75 Xie (10.1016/j.bioactmat.2020.08.006_bib31) 2015; 4 Wang (10.1016/j.bioactmat.2020.08.006_bib49) 2015; 91 Alipour (10.1016/j.bioactmat.2020.08.006_bib23) 2010; 81 |
| References_xml | – volume: 9 start-page: 8362 year: 2019 end-page: 8376 ident: bib8 article-title: Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy publication-title: Theranostics – volume: 19 start-page: 417 year: 2014 end-page: 427 ident: bib17 article-title: Biopolymer-based nanoparticles and microparticles: fabrication, characterization, and application publication-title: Curr. Opin. Colloid Interface Sci. – volume: 33 start-page: 1855 year: 2015 end-page: 1867 ident: bib28 article-title: Silk sericin: a versatile material for tissue engineering and drug delivery publication-title: Biotechnol. Adv. – volume: 29 start-page: 3014 year: 2008 end-page: 3022 ident: bib15 article-title: Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer publication-title: Biomaterials – volume: 80 start-page: 154 year: 2018 end-page: 168 ident: bib36 article-title: Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats publication-title: Acta Biomater. – volume: 122 start-page: 498 year: 2014 end-page: 504 ident: bib21 article-title: Combination of doxorubicin-based chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles publication-title: Colloids Surf., B – volume: 47 start-page: S38 year: 2011 end-page: S47 ident: bib5 article-title: The role of chemotherapy and targeted agents in patients with metastatic breast cancer publication-title: Eur. J. Canc. – volume: 16 start-page: 1735 year: 1999 end-page: 1742 ident: bib50 article-title: Formulation and physical characterization of large porous particles for inhalation publication-title: Pharm. Res. (N. Y.) – volume: 29 start-page: 573 year: 2016 end-page: 591 ident: bib40 article-title: Iron uptake and transport across physiological barriers publication-title: Biometals – volume: 41 start-page: 123 year: 2018 end-page: 140 ident: bib3 article-title: Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis publication-title: Cell. Oncol. – volume: 81 start-page: 521 year: 2010 end-page: 529 ident: bib23 article-title: Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery publication-title: Colloids Surf., B – volume: 8 start-page: 6411 year: 2016 end-page: 6422 ident: bib34 article-title: Sericin/dextran injectable hydrogel as an optically trackable drug delivery system for malignant melanoma treatment publication-title: ACS Appl. Mater. Interfaces – volume: 341 start-page: 154 year: 2013 end-page: 157 ident: bib41 article-title: One-step assembly of coordination complexes for versatile film and particle engineering publication-title: Science – volume: 24 start-page: 7432 year: 2008 end-page: 7441 ident: bib22 article-title: Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2 publication-title: Langmuir – volume: 333 start-page: 5 year: 2007 end-page: 9 ident: bib51 article-title: Long acting porous microparticle for pulmonary protein delivery publication-title: Int. J. Pharm. – volume: 40 start-page: 558 year: 2014 end-page: 566 ident: bib2 article-title: The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets publication-title: Canc. Treat Rev. – volume: 12 start-page: 136 year: 2017 end-page: 148 ident: bib39 article-title: Metal-phenolic networks as a versatile platform to engineer nanomaterials and biointerfaces publication-title: Nano Today – volume: 180 start-page: 16 year: 2017 end-page: 23 ident: bib4 article-title: Treatment advances in small cell lung cancer (SCLC) publication-title: Pharmacol. Ther. – volume: 5 start-page: 3007 year: 2009 end-page: 3020 ident: bib30 article-title: Novel silk sericin/gelatin 3-D scaffolds and 2-D films: fabrication and characterization for potential tissue engineering applications publication-title: Acta Biomater. – volume: 4 start-page: 7064 year: 2014 end-page: 7074 ident: bib29 article-title: Exploring natural silk protein sericin for regenerative medicine: an injectable, photoluminescent, cell-adhesive 3D hydrogel publication-title: Sci. Rep. – volume: 269 start-page: 374 year: 2018 end-page: 392 ident: bib27 article-title: Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates publication-title: J. Contr. Release – volume: 10 start-page: 26473 year: 2018 end-page: 26484 ident: bib43 article-title: Supramolecular modular approach toward conveniently constructing and multifunctioning a pH/redox dual-responsive drug delivery nanoplatform for improved cancer chemotherapy publication-title: ACS Appl. Mater. Interfaces – volume: 75 start-page: 92 year: 2014 end-page: 111 ident: bib14 article-title: Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies publication-title: Adv. Drug Deliv. Rev. – volume: 7 start-page: 1551 year: 2012 end-page: 1572 ident: bib16 article-title: Inhaled chemotherapy in lung cancer: future concept of nanomedicine publication-title: Int. J. Nanomed. – volume: 88 start-page: 1086 year: 2014 end-page: 1093 ident: bib19 article-title: Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment publication-title: Eur. J. Pharm. Biopharm. – volume: 75 start-page: 81 year: 2014 end-page: 91 ident: bib12 article-title: Delivery strategies for sustained drug release in the lungs publication-title: Adv. Drug Deliv. Rev. – volume: 163 start-page: 89 year: 2018 end-page: 104 ident: bib32 article-title: Photo-crosslinkable, injectable sericin hydrogel as 3D biomimetic extracellular matrix for minimally invasive repairing cartilage publication-title: Biomaterials – volume: 61 start-page: 940 year: 2016 end-page: 952 ident: bib38 article-title: Processing and characterization of silk sericin from Bombyx mori and its application in biomaterials and biomedicines publication-title: Mater. Sci. Eng. C – volume: 34 start-page: 7744 year: 2013 end-page: 7753 ident: bib54 article-title: In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models publication-title: Biomaterials – volume: 4 start-page: 2195 year: 2015 end-page: 2205 ident: bib31 article-title: A silk sericin/silicone nerve guidance conduit promotes regeneration of a transected sciatic nerve publication-title: Adv. Healthc. Mater. – volume: 91 start-page: 125 year: 2015 end-page: 140 ident: bib49 article-title: Non-genetic engineering of cells for drug delivery and cell-based therapy publication-title: Adv. Drug Deliv. Rev. – volume: 61 start-page: 428 year: 2009 end-page: 437 ident: bib44 article-title: Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy publication-title: Adv. Drug Deliv. Rev. – volume: 12 start-page: 1009 year: 2015 end-page: 1026 ident: bib7 article-title: Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages publication-title: Expet Opin. Drug Deliv. – volume: 458 start-page: 217 year: 2003 end-page: 225 ident: bib46 article-title: Piperlactam S suppresses macrophage migration by impeding F-actin polymerization and filopodia extension publication-title: Eur. J. Pharmacol. – volume: 28 start-page: S4 year: 2009 end-page: S13 ident: bib6 article-title: Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs publication-title: Oncogene – volume: 133 start-page: 107 year: 2018 end-page: 130 ident: bib18 article-title: The potential to treat lung cancer via inhalation of repurposed drugs publication-title: Adv. Drug Deliv. Rev. – volume: 33 start-page: 5574 year: 2012 end-page: 5583 ident: bib10 article-title: Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer publication-title: Biomaterials – volume: 53 start-page: 688 year: 2015 end-page: 698 ident: bib26 article-title: Mesenchymal stem cells attenuated PLGA-induced inflammatory responses by inhibiting host DC maturation and function publication-title: Biomaterials – volume: 4 year: 2018 ident: bib37 article-title: Advanced silk fibroin biomaterials for cartilage regeneration publication-title: ACS Biomater. Sci. Eng. – volume: 107 start-page: 153 year: 2016 end-page: 162 ident: bib25 article-title: Biocompatibility and safety of PLA and its copolymers publication-title: Adv. Drug Deliv. Rev. – volume: 30 start-page: 217 year: 2012 end-page: 224 ident: bib42 article-title: Potential applications of silk sericin, a natural protein from textile industry by-products publication-title: Waste Manag. Res. – volume: 8 start-page: 6577 year: 2016 end-page: 6585 ident: bib33 article-title: Design and fabrication of multifunctional sericin nanoparticles for tumor targeting and pH-responsive subcellular delivery of cancer chemotherapy drugs publication-title: ACS Appl. Mater. Interfaces – volume: 583 start-page: 119338 year: 2020 end-page: 119345 ident: bib24 article-title: Developing spray-freeze-dried particles containing a hyaluronic acid-coated liposome-protamine-DNA complex for pulmonary inhalation publication-title: Int. J. Pharm. – volume: 158 start-page: 329 year: 2012 end-page: 335 ident: bib20 article-title: Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery publication-title: J. Contr. Release – volume: 8 start-page: 563 year: 2018 end-page: 574 ident: bib9 article-title: Local intratracheal delivery of perfluorocarbon nanoparticles to lung cancer demonstrated with magnetic resonance multimodal imaging publication-title: Theranostics – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA A Cancer J. Clin. – volume: 39 start-page: 20.2.1 year: 2000 end-page: 20.2.16 ident: bib47 article-title: Mouse 4T1 breast tumor model publication-title: Curr. Protoc. Immunol. – volume: 10 start-page: 6987 year: 2020 end-page: 7001 ident: bib53 article-title: TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy publication-title: Theranostics – volume: 10 start-page: 741 year: 2020 end-page: 756 ident: bib35 article-title: A sericin/graphene oxide composite scaffold as a biomimetic extracellular matrix for structural and functional repair of calvarial bone publication-title: Theranostics – volume: 34 start-page: 6444 year: 2013 end-page: 6453 ident: bib11 article-title: Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer publication-title: Biomaterials – volume: 23 start-page: 3319 year: 2018 end-page: 3335 ident: bib45 article-title: Schisandra chinensis lignans suppresses the production of inflammatory mediators regulated by NF-kappaB, AP-1, and IRF3 in lipopolysaccharide-stimulated RAW264.7 cells publication-title: Molecules – volume: 38 start-page: 782 year: 2017 end-page: 797 ident: bib13 article-title: Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities publication-title: Acta Pharmacol. Sin. – volume: 35 start-page: 75 year: 2016 end-page: 91 ident: bib48 article-title: Progression and metastasis of lung cancer publication-title: Canc. Metastasis Rev. – volume: 53 start-page: 5546 year: 2014 end-page: 5551 ident: bib52 article-title: Engineering multifunctional capsules through the assembly of metal-phenolic networks publication-title: Angew. Chem., Int. Ed. Engl. – volume: 583 start-page: 119338 year: 2020 ident: 10.1016/j.bioactmat.2020.08.006_bib24 article-title: Developing spray-freeze-dried particles containing a hyaluronic acid-coated liposome-protamine-DNA complex for pulmonary inhalation publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2020.119338 – volume: 107 start-page: 153 year: 2016 ident: 10.1016/j.bioactmat.2020.08.006_bib25 article-title: Biocompatibility and safety of PLA and its copolymers publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2016.03.012 – volume: 47 start-page: S38 year: 2011 ident: 10.1016/j.bioactmat.2020.08.006_bib5 article-title: The role of chemotherapy and targeted agents in patients with metastatic breast cancer publication-title: Eur. J. Canc. doi: 10.1016/S0959-8049(11)70145-9 – volume: 12 start-page: 1009 year: 2015 ident: 10.1016/j.bioactmat.2020.08.006_bib7 article-title: Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages publication-title: Expet Opin. Drug Deliv. doi: 10.1517/17425247.2015.1039509 – volume: 19 start-page: 417 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib17 article-title: Biopolymer-based nanoparticles and microparticles: fabrication, characterization, and application publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/j.cocis.2014.07.002 – volume: 4 start-page: 2195 year: 2015 ident: 10.1016/j.bioactmat.2020.08.006_bib31 article-title: A silk sericin/silicone nerve guidance conduit promotes regeneration of a transected sciatic nerve publication-title: Adv. Healthc. Mater. doi: 10.1002/adhm.201500355 – volume: 61 start-page: 940 year: 2016 ident: 10.1016/j.bioactmat.2020.08.006_bib38 article-title: Processing and characterization of silk sericin from Bombyx mori and its application in biomaterials and biomedicines publication-title: Mater. Sci. Eng. C doi: 10.1016/j.msec.2015.12.082 – volume: 29 start-page: 573 year: 2016 ident: 10.1016/j.bioactmat.2020.08.006_bib40 article-title: Iron uptake and transport across physiological barriers publication-title: Biometals doi: 10.1007/s10534-016-9952-2 – volume: 91 start-page: 125 year: 2015 ident: 10.1016/j.bioactmat.2020.08.006_bib49 article-title: Non-genetic engineering of cells for drug delivery and cell-based therapy publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2014.12.003 – volume: 333 start-page: 5 year: 2007 ident: 10.1016/j.bioactmat.2020.08.006_bib51 article-title: Long acting porous microparticle for pulmonary protein delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2007.01.016 – volume: 9 start-page: 8362 year: 2019 ident: 10.1016/j.bioactmat.2020.08.006_bib8 article-title: Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy publication-title: Theranostics doi: 10.7150/thno.39816 – volume: 8 start-page: 563 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib9 article-title: Local intratracheal delivery of perfluorocarbon nanoparticles to lung cancer demonstrated with magnetic resonance multimodal imaging publication-title: Theranostics doi: 10.7150/thno.21466 – volume: 122 start-page: 498 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib21 article-title: Combination of doxorubicin-based chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2014.07.020 – volume: 4 start-page: 7064 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib29 article-title: Exploring natural silk protein sericin for regenerative medicine: an injectable, photoluminescent, cell-adhesive 3D hydrogel publication-title: Sci. Rep. doi: 10.1038/srep07064 – volume: 341 start-page: 154 year: 2013 ident: 10.1016/j.bioactmat.2020.08.006_bib41 article-title: One-step assembly of coordination complexes for versatile film and particle engineering publication-title: Science doi: 10.1126/science.1237265 – volume: 24 start-page: 7432 year: 2008 ident: 10.1016/j.bioactmat.2020.08.006_bib22 article-title: Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2 publication-title: Langmuir doi: 10.1021/la703900k – volume: 39 start-page: 20.2.1 year: 2000 ident: 10.1016/j.bioactmat.2020.08.006_bib47 article-title: Mouse 4T1 breast tumor model publication-title: Curr. Protoc. Immunol. doi: 10.1002/0471142735.im2002s39 – volume: 53 start-page: 5546 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib52 article-title: Engineering multifunctional capsules through the assembly of metal-phenolic networks publication-title: Angew. Chem., Int. Ed. Engl. doi: 10.1002/anie.201311136 – volume: 163 start-page: 89 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib32 article-title: Photo-crosslinkable, injectable sericin hydrogel as 3D biomimetic extracellular matrix for minimally invasive repairing cartilage publication-title: Biomaterials doi: 10.1016/j.biomaterials.2018.02.016 – volume: 33 start-page: 1855 year: 2015 ident: 10.1016/j.bioactmat.2020.08.006_bib28 article-title: Silk sericin: a versatile material for tissue engineering and drug delivery publication-title: Biotechnol. Adv. doi: 10.1016/j.biotechadv.2015.10.014 – volume: 34 start-page: 6444 year: 2013 ident: 10.1016/j.bioactmat.2020.08.006_bib11 article-title: Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.05.018 – volume: 4 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib37 article-title: Advanced silk fibroin biomaterials for cartilage regeneration publication-title: ACS Biomater. Sci. Eng. doi: 10.1021/acsbiomaterials.8b00150 – volume: 7 start-page: 1551 year: 2012 ident: 10.1016/j.bioactmat.2020.08.006_bib16 article-title: Inhaled chemotherapy in lung cancer: future concept of nanomedicine publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S29997 – volume: 80 start-page: 154 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib36 article-title: Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats publication-title: Acta Biomater. doi: 10.1016/j.actbio.2018.09.013 – volume: 29 start-page: 3014 year: 2008 ident: 10.1016/j.bioactmat.2020.08.006_bib15 article-title: Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2008.03.033 – volume: 8 start-page: 6411 year: 2016 ident: 10.1016/j.bioactmat.2020.08.006_bib34 article-title: Sericin/dextran injectable hydrogel as an optically trackable drug delivery system for malignant melanoma treatment publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.6b00959 – volume: 133 start-page: 107 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib18 article-title: The potential to treat lung cancer via inhalation of repurposed drugs publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2018.08.012 – volume: 35 start-page: 75 year: 2016 ident: 10.1016/j.bioactmat.2020.08.006_bib48 article-title: Progression and metastasis of lung cancer publication-title: Canc. Metastasis Rev. doi: 10.1007/s10555-016-9618-0 – volume: 88 start-page: 1086 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib19 article-title: Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2014.09.012 – volume: 10 start-page: 26473 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib43 article-title: Supramolecular modular approach toward conveniently constructing and multifunctioning a pH/redox dual-responsive drug delivery nanoplatform for improved cancer chemotherapy publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.8b05232 – volume: 75 start-page: 81 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib12 article-title: Delivery strategies for sustained drug release in the lungs publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2014.05.017 – volume: 68 start-page: 394 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA A Cancer J. Clin. doi: 10.3322/caac.21492 – volume: 81 start-page: 521 year: 2010 ident: 10.1016/j.bioactmat.2020.08.006_bib23 article-title: Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2010.07.050 – volume: 30 start-page: 217 year: 2012 ident: 10.1016/j.bioactmat.2020.08.006_bib42 article-title: Potential applications of silk sericin, a natural protein from textile industry by-products publication-title: Waste Manag. Res. doi: 10.1177/0734242X11404733 – volume: 180 start-page: 16 year: 2017 ident: 10.1016/j.bioactmat.2020.08.006_bib4 article-title: Treatment advances in small cell lung cancer (SCLC) publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2017.06.002 – volume: 158 start-page: 329 year: 2012 ident: 10.1016/j.bioactmat.2020.08.006_bib20 article-title: Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery publication-title: J. Contr. Release doi: 10.1016/j.jconrel.2011.10.030 – volume: 23 start-page: 3319 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib45 article-title: Schisandra chinensis lignans suppresses the production of inflammatory mediators regulated by NF-kappaB, AP-1, and IRF3 in lipopolysaccharide-stimulated RAW264.7 cells publication-title: Molecules doi: 10.3390/molecules23123319 – volume: 75 start-page: 92 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib14 article-title: Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2014.05.008 – volume: 34 start-page: 7744 year: 2013 ident: 10.1016/j.bioactmat.2020.08.006_bib54 article-title: In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.06.041 – volume: 28 start-page: S4 year: 2009 ident: 10.1016/j.bioactmat.2020.08.006_bib6 article-title: Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs publication-title: Oncogene doi: 10.1038/onc.2009.196 – volume: 269 start-page: 374 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib27 article-title: Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates publication-title: J. Contr. Release doi: 10.1016/j.jconrel.2017.11.036 – volume: 33 start-page: 5574 year: 2012 ident: 10.1016/j.bioactmat.2020.08.006_bib10 article-title: Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.04.018 – volume: 40 start-page: 558 year: 2014 ident: 10.1016/j.bioactmat.2020.08.006_bib2 article-title: The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets publication-title: Canc. Treat Rev. doi: 10.1016/j.ctrv.2013.10.001 – volume: 41 start-page: 123 year: 2018 ident: 10.1016/j.bioactmat.2020.08.006_bib3 article-title: Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis publication-title: Cell. Oncol. doi: 10.1007/s13402-018-0376-6 – volume: 38 start-page: 782 year: 2017 ident: 10.1016/j.bioactmat.2020.08.006_bib13 article-title: Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2017.34 – volume: 458 start-page: 217 year: 2003 ident: 10.1016/j.bioactmat.2020.08.006_bib46 article-title: Piperlactam S suppresses macrophage migration by impeding F-actin polymerization and filopodia extension publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(02)02733-4 – volume: 53 start-page: 688 year: 2015 ident: 10.1016/j.bioactmat.2020.08.006_bib26 article-title: Mesenchymal stem cells attenuated PLGA-induced inflammatory responses by inhibiting host DC maturation and function publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.03.005 – volume: 10 start-page: 741 year: 2020 ident: 10.1016/j.bioactmat.2020.08.006_bib35 article-title: A sericin/graphene oxide composite scaffold as a biomimetic extracellular matrix for structural and functional repair of calvarial bone publication-title: Theranostics doi: 10.7150/thno.39502 – volume: 8 start-page: 6577 year: 2016 ident: 10.1016/j.bioactmat.2020.08.006_bib33 article-title: Design and fabrication of multifunctional sericin nanoparticles for tumor targeting and pH-responsive subcellular delivery of cancer chemotherapy drugs publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.5b11617 – volume: 61 start-page: 428 year: 2009 ident: 10.1016/j.bioactmat.2020.08.006_bib44 article-title: Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2009.03.009 – volume: 16 start-page: 1735 year: 1999 ident: 10.1016/j.bioactmat.2020.08.006_bib50 article-title: Formulation and physical characterization of large porous particles for inhalation publication-title: Pharm. Res. (N. Y.) doi: 10.1023/A:1018910200420 – volume: 12 start-page: 136 year: 2017 ident: 10.1016/j.bioactmat.2020.08.006_bib39 article-title: Metal-phenolic networks as a versatile platform to engineer nanomaterials and biointerfaces publication-title: Nano Today doi: 10.1016/j.nantod.2016.12.012 – volume: 5 start-page: 3007 year: 2009 ident: 10.1016/j.bioactmat.2020.08.006_bib30 article-title: Novel silk sericin/gelatin 3-D scaffolds and 2-D films: fabrication and characterization for potential tissue engineering applications publication-title: Acta Biomater. doi: 10.1016/j.actbio.2009.03.026 – volume: 10 start-page: 6987 year: 2020 ident: 10.1016/j.bioactmat.2020.08.006_bib53 article-title: TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy publication-title: Theranostics doi: 10.7150/thno.44569 |
| SSID | ssj0001700007 |
| Score | 2.3195903 |
| Snippet | Chemotherapy is one of the major approaches for the treatment of metastatic lung cancer. However, systemic chemotherapy is limited by poor therapeutic... |
| SourceID | doaj pubmedcentral proquest crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 273 |
| SubjectTerms | Doxorubicin Metal organic networks Metastatic lung cancer Pulmonary delivery system Sericin microparticles |
| Title | Sericin microparticles enveloped with metal-organic networks as a pulmonary targeting delivery system for intra-tracheally treating metastatic lung cancer |
| URI | https://dx.doi.org/10.1016/j.bioactmat.2020.08.006 https://www.proquest.com/docview/2441614544 https://pubmed.ncbi.nlm.nih.gov/PMC7451883 https://doaj.org/article/6c2f9582cb9c40baad0471f748b742b2 |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQCBALtDISVwsncRKHW4uoqkrlRKW9Wf6YiFRpdrXdPfSv8GuZsZNVctoLUvaSdSzHM_G8cV7eMPYVkwbE0VkQ4MpCKLBO2LZQIlD5OIUhydb07fDdr-rmXt2uy_Ws1BdxwpI8cJq4b5XP26bUuXeNV9JZGySup22ttMOszsXVF2PeLJl6SKIwFP2ospwqc2JTrBfkLtdtrN8jJsQMMZdRxJNqHs1CU1TwX0SoGQJd8idnAen6NXs1Ikl-me7gDXsBw1v2l3a7fDfwRyLabSfaG4chcoMgcNp45Y-AmFukik6eD4kK_sQtHnx76NE17e6ZJ5Y4xjYeoCf-xjNPws8ckS7vaFQCf57AZo_NI_7E1tQ7faiEXfe4lnBPnrV7x-6vf_7-cSPG8gvCl5neC4AMbF5CyGoIuqqtlTZvAlqvIR121bZtJqXFBcqhcRotvaubAE4WIKVrVPGenQ2bAT4w7jMfbKtl8G3AhDLXEhAXVI1zoBFj6BWrppk3ftQmpxIZvZlIaA_maDJDJjNUPFNWKyaPF26TPMfpS67ItMfmpK8dT-Ckm9Es5pTXrdj3yTHMCFUSBMGuutMj-DK5ksGHmd7Q2AE2hyeDWAsRuCqVWrF64WOL4S7_Gbo_URa8ViSuV3z8H_f3ib3MibwT95o-s7P97gDniL727iI-aP8AIK80LQ |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sericin+microparticles+enveloped+with+metal-organic+networks+as+a+pulmonary+targeting+delivery+system+for+intra-tracheally+treating+metastatic+lung+cancer&rft.jtitle=Bioactive+materials&rft.au=Liu%2C+Jia&rft.au=Deng%2C+Yan&rft.au=Fu%2C+Daan&rft.au=Yuan%2C+Ye&rft.date=2021-01-01&rft.pub=Elsevier+B.V&rft.issn=2452-199X&rft.eissn=2452-199X&rft.volume=6&rft.issue=1&rft.spage=273&rft.epage=284&rft_id=info:doi/10.1016%2Fj.bioactmat.2020.08.006&rft.externalDocID=S2452199X20301523 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2452-199X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2452-199X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2452-199X&client=summon |